3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Investors looking for growth in recent times have piled into stocks in artificial intelligence and quantum computing. But these aren't the only areas that offer the potential for explosive revenue growth and stock performance. Another industry also offers innovation and even game-changing products -- elements that could drive long-term returns for your portfolio.This industry is biotech. Companies in the space often focus on the research and development of cutting-edge technologies such as gene editing or messenger RNA to power the medicines of tomorrow. Sometimes these companies, due to their lack of products on the market or limited revenue, may trade at bargain levels. But they might have what it takes to soar down the road if their products reach commercialization.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool